Lipid-based carriers: Manufacturing and applications for pulmonary route

Expert Opinion on Drug Delivery

Volumn 9, Issue 9, 2012, Pages 1111-1127

  Jaafar Maalej, Chiraz ^a   Elaissari, Abdelhamid ^a   Fessi, Hatem ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Aerosol; Liposomes; Lung; Preparation methods; Pulmonary drug delivery; Solid lipid nanoparticles; Therapeutic applications

Indexed keywords

AMIKACIN; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ARIKACE; BECLOMETASONE DIPROPIONATE; BERACTANT; BUDESONIDE; CARBON DIOXIDE; CYCLOSPORIN; DAUNORUBICIN; DEXAMETHASONE; DIAZEPAM; DOXORUBICIN; EPIRUBICIN; FLUORESCEIN; INSULIN; ISONIAZID; ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; LIPID EMULSION; LIPOSOME; PACLITAXEL; RIFAMPICIN; RUBITECAN; SOLID LIPID NANOPARTICLE; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ASTHMA; BIOAVAILABILITY; BIOCOMPATIBILITY; CELL VIABILITY; CROSSFLOW FILTRATION; CYTOTOXICITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; EMULSION; ENCAPSULATION; FREEZE DRYING; FREEZE THAWING; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; INGUINAL LYMPH NODE; KIDNEY CARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG HOMOGENATE; LUNG LAVAGE; LUNG METASTASIS; MELANOMA; MICROEMULSION; MICROFLUIDICS; MINIMUM INHIBITORY CONCENTRATION; NEBULIZATION; OSTEOSARCOMA; PARTICLE SIZE; PHOSPHOLIPID BILAYER; POWDER INHALER; RESPIRATORY DISTRESS SYNDROME; REVERSE MICELLE; REVIEW; SUPERCRITICAL FLUID; SUPERCRITICAL FLUID EXTRACTION; TRANSITION TEMPERATURE; TUBERCULOSIS; ZETA POTENTIAL;

ADMINISTRATION, INHALATION; ANIMALS; BIOLOGICAL TRANSPORT; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; LIPOSOMES; LUNG; NANOPARTICLES;

EID: 84865317556     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.702751     Document Type: Review

References (105)

1. Sung JC, Pulliam BL, Edwards DA. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007;25:563-70 (Pubitemid 350138179)
2. Yamamoto H, Kuno Y, Sugimoto S, et al. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Control Release 2005;102:373-81 (Pubitemid 40093760)
3. Suarez S, Hickey AJ. Drug properties affecting aerosol behavior. Respir Care 2000;45:652-66 (Pubitemid 30484805)
4. Zeng X, Martin G, Marriott C. Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drag delivery system. Eur J Pharm Sci 1995;3:87-93
5. Schreier H, Gonzalez-Rothib R, Stecenko A. Pulmonary delivery of liposomes. J Control Release 1993;24:209-23 (Pubitemid 23161333)
6. Twigg HL. Pulmonary host defenses. J Thorac Imaging 1998;13:221-33
7. Nicod LP. Pulmonary defence mechanisms. Respiration 1999;66:2-11 (Pubitemid 29089985)
8. Dailey LA, Schmehl T, Gessler T, et al. Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features. J Control Release 2003;86:131-44 (Pubitemid 35461980)
9. Courrier HM, Butz N, Vandamme TF. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 2002;19:425-98 (Pubitemid 36314479)
10. Taylor G, Kellaway I. Pulmonary drug delivery. In: Hillery A, Lloyd A, Swarbrick J, editors. Drug Delivery And Targeting. Taylor & Francis; New York: 2001. p. 269-300
11. Newman SP. Aerosol deposition considerations in inhalation therapy. Chest 1985;88:152S-60S (Pubitemid 16246728)
12. Bangham A, Horne RW. Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. J Mol Biol 1964;8:660-8
13. Parthasarathy R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother Pharmacol 1999;43:277-83 (Pubitemid 29075883)
14. Sweeney LG, Wang Z, Loebenberg R, et al. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm 2005;305:180-5 (Pubitemid 41568373)
15. Pandey R, Khuller GK. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb) 2005a85:227-34 (Pubitemid 40805619)
16. Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 1995;12:229-46
17. Gregoriadis G. The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med 1976;295:765-70
18. Fendler JH, Romero A. Liposomes as drug carriers. Life Sci 1977;20:1109-20 (Pubitemid 8086779)
19. Sharma A, Sharma U. Liposomes in drug delivery: progress and limitations. Int J Pharm 1997;154:123-40 (Pubitemid 27351317)
20. Eichler H, Senior J, Stadler A, et al. Kinetics and disposition of fluorescein-labelled liposomes in healthy human subjects. Eur J Clin Pharmacol 1988;34:475-9
21. Thomas D, Myers M, Wichert B, et al. Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. Chest 1991;99:1268-70
22. Waldrep JC, Gilbert BE, Knight CM, et al. Pulmonary delivery of beclomethasone liposome aerosol in volunteers. tolerance and safety. Chest 1997;111:316-23 (Pubitemid 27096944)
23. Lasic D, Papadjopoulos D. Liposomes revisited. Science 1995;267:1275-6
24. Kim S, Turker MS, Chi EY, et al. Preparation of multivesicular liposomes. Biochim Biophys Acta 1983;728:339-48
25. Szoka FJ, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978;75:4194-8 (Pubitemid 9025976)
26. Mozafari MR. Liposomes: an overview of manufacturing techniques. Cell Mol Biol Lett 2005;10:711-19 (Pubitemid 43161695)
27. Meure LA, Foster NR, Dehghani F. Conventional and dense gas techniques for the production of liposomes: a review. AAPS PharmSciTech 2008;9:798-809
28. Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004;7:252-9 (Pubitemid 41528899)
29. Deamer D, Bangham AD. Large volume liposomes by an ether vaporization method. Biochim Biophys Acta 1976;443:629-34
30. Schieren H, Rudolph S, Finkelstein M, et al. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. Biochim Biophys Acta 1978;542:137-53 (Pubitemid 8394755)
31. Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 1973;298:1015-19
32. Pons M, Foradada M, Estelrich J. Liposomes obtained by the ethanol injection method. Int J Pharm 1993;95:51-6 (Pubitemid 23203135)
33. Luna EJ, McConnell HM. The intermediate monoclinic phase of phosphatidylcholines. Biochim Biophys Acta 1977;466:381-92 (Pubitemid 8074962)
34. Lasic DD. A molecular model for vesicle formation. Biochim Biophys Acta 1982;692:501-2
35. Pick U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch Biochem Biophys 1981;212:186-94
36. Li C, Deng Y. A novel method for the preparation of liposomes: freeze drying of monophase solutions. J Pharm Sci 2004;93:1403-14 (Pubitemid 38725015)
37. Cui J, Li C, Deng Y, et al. Freeze-drying of liposomes using tertiary butyl alcohol/water cosolvent systems. Int J Pharm 2006;312:131-6
38. Wang T, Deng Y, Geng Y, et al. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 2006;1758:222-31 (Pubitemid 44294663)
39. Mozafari MR, Reed CJ, Rostron C, et al. Formation and characterisation of non-toxic anionic liposomes for delivery of therapeutic agents to the pulmonary airways. Cell Mol Biol Lett 2002;a7:243-4
40. Mozafari MR, Reed CJ, Rostron C, et al. Construction of stable anionic liposome-plasmid particles using the heating method: a preliminary investigation. Cell Mol Biol Lett 2002b7:923-7 (Pubitemid 35334385)
41. Wagner A, Vorauer-Uhl K, Kreismayr G, et al. The crossflow injection technique: an improvement of the ethanol injection method. J Liposome Res 2002a12:259-70 (Pubitemid 35403645)
42. Wagner A, Vorauer-Uhl K, Kreismayr G, et al. Enhanced protein loading into liposomes by the multiple crossflow injection technique. J Liposome Res 2002b12:271-83 (Pubitemid 35403646)
43. Wagner A, Platzgummer M, Kreismayr G, et al. GMP production of liposomes-a new industrial approach. J Liposome Res 2006;16:311-19 (Pubitemid 44362501)
44. Jahn A, Vreeland WN, Gaitan M, et al. Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing. J Am Chem Soc 2004;126:2674-5 (Pubitemid 38314254)
45. Jahn A, Reiner J, Vreeland W, et al. Preparation of nanoparticles by continuous-flow microfluidics. J Nanopart Res 2008;10:925-34
46. Jahn A, Vreeland WN, DeVoe DL, et al. Microfluidic directed formation of liposomes of controlled size. Langmuir 2007;23:6289-93 (Pubitemid 46880969)
47. Jaafar-Maalej C, Charcosset C, Fessi H. A new method for liposome preparation using a membrane contactor. J Lipid Res 2011;21:213-20
48. Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol Adv 2006;24:482-92 (Pubitemid 44088447)
49. Laouini A, Jaafar-Maalej C, Sfar S, et al. Liposome preparation using a hollow fiber membrane contactor-application to spironolactone encapsulation. Int J Pharm 2011;415:53-61
50. Castor TP. Phospholipid nanosomes. Curr Drug Deliv 2005;2:329-40 (Pubitemid 41277765)
51. Frederiksen L, Anton K, van Hoogevest P, et al. Preparation of liposomes encapsulating water-soluble compounds using supercritical carbon dioxide. J Pharm Sci 1997;86:921-8 (Pubitemid 27344050)
52. Otake K, Imura T, Sakai H, et al. Development of a new preparation method of liposomes using supercritical carbon dioxide. Langmuir 2001;17:3898-901 (Pubitemid 35330339)
53. Otake K, Shimomura T, Goto T, et al. Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 2006;22:2543-50
54. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96 (Pubitemid 32324113)
55. Almeida A, Runge S, Muller R. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm 1997;149:255-65 (Pubitemid 27193412)
56. Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002;241:341-4 (Pubitemid 34718035)
57. Muller RH, Maassen S, Weyhers H, et al. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. J Drug Target 1996;4:161-70 (Pubitemid 26390298)
58. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77 (Pubitemid 30326695)
59. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003;257:153-60 (Pubitemid 36507041)
60. Hou D, Xie C, Huang K, et al. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781-5 (Pubitemid 36184733)
61. Gasco M. Method for producing solid lipid microspheres having a narrow size distribution. 1993; USP 5.250.236
62. Hu F, Jiang S, Du Y, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces 2005;45:167-73 (Pubitemid 41415646)
63. Quintanar-Guerrero D, Tamayo-Esquivel D, Ganem-Quintanar A, et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci 2005;26:211-18 (Pubitemid 41169804)
64. Schubert MA, Muller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur J Pharm Biopharm 2003;55:125-31 (Pubitemid 36120504)
65. Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005;108:112-20 (Pubitemid 41476679)
66. Chattopadhyay P, Shekunov BY, Yim D, et al. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007;59:444-53 (Pubitemid 47259225)
67. Gershkovich P, Wasan KM, Barta CA. A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev Ther Drug Carrier Syst 2008;25:545-84
68. Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Deliv Formul 2008;2:120-35
69. Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004;56:1527-35 (Pubitemid 39601993)
70. Muller RH, Runge S, Ravelli V, et al. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm 2006;317:82-9 (Pubitemid 43866342)
71. Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine 2007;2:289-300 (Pubitemid 350047774)
72. Videira MA, Botelho MF, Santos AC, et al. Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002;10:607-13 (Pubitemid 36124361)
73. Xiang Q, Wang M, Chen F, et al. Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles. Arch Pharm Res 2007;30:519-25
74. Zhang P, Tu Y, Wang S, et al. Preparation and characterization of budesonide-loaded solid lipid nanoparticles for pulmonary delivery. J Chin Pharm Sci 2011;20:390-6
75. Abdelbary G, Fahmy R. Diazepam-Loaded Solid Lipid Nanoparticles: design and Characterization. AAPS Pharm Sci Tec 2009;10:211-19
76. Videira M, Almeida AJ, Fabra A. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomedicine 2011;in Press
77. Yu W, Liu C, Liu Y, et al. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 2010;27:1584-96
78. Taylor K, Taylor G, Kellaway I, et al. The stability of liposomes to nebulisation. Int J Pharm 1990;58:57-61 (Pubitemid 20034228)
79. Misra A, Jinturkar K, Patel D, et al. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin Drug Deliv 2009;6:71-89
80. Bi R, Shao W, Wang Q, et al. Solid Lipid Nanoparticles as insulin inhalation carriers for enhanced pulmonary deliver. J Biomed Nanotechnol 2009;5:84-92
81. Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 2009;29:196-212
82. Knight V, Koshkina N, Waldrep C, et al. Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice. Trans Am Clin Climatol Assoc 2000;111:135-45
83. Koshkina NV, Kleinerman ES, Waidrep C, et al. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res 2000;6:2876-80 (Pubitemid 30482130)
84. Zhang L, Xing B, Wu J, et al. Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Pulm Pharmacol Ther 2008;21:239-46
85. Verschraegen CF, Gilbert BE, Loyer E, et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 2004;10:2319-26 (Pubitemid 38445689)
86. Koshkina NV, Waldrep JC, Roberts LE, et al. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 2001;7:3258-62 (Pubitemid 32963851)
87. Trammer B, Amann A, Haltner-Ukomadu E, et al. Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo. Eur J Pharm Biopharm 2008;70:758-64
88. Behr J, Zimmermann G, Baumgartner R, et al. Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation. J Aerosol Med Pulm Drug Deliv 2009;22:121-30
89. Ruijgrok EJ, Vulto AG, Van Etten EW. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats. J Pharm Pharmacol 2000;52:619-27 (Pubitemid 30410074)
90. Vyas SP, Quraishi S, Gupta S, et al. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm 2005;296:12-25 (Pubitemid 40693368)
91. Vyas SP, Kannan ME, Jain S, et al. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004;269:37-49 (Pubitemid 38035210)
92. Zaru M, Mourtas S, Klepetsanis P, et al. Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 2007;67:655-66 (Pubitemid 47576612)
93. Zaru M, Manca M, Fadda AM, et al. Chitosan-coated liposomes for delivery to lungs by nebulisation. Colloids Surf B Biointerfaces 2009;71:88-95
94. Zaru M, Sinico C, De Logu A, et al. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation. J Liposome Res 2009;19:68-76
95. Li Z, Zhang Y, Wurtz W, et al. Characterization of nebulized liposomal amikacin (Arikace) as a function of droplet size. J Aerosol Med Pulm Drug Deliv 2008;21:245-54
96. Weers J, Metzheiser B, Taylor G, et al. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers. J Aerosol Med Pulm Drug Deliv 2009;22:131-8
97. Joshi M, Misra AN. Pulmonary disposition of budesonide from liposomal dry powder inhaler. Methods Find Exp Clin Pharmacol 2001;23:531-6 (Pubitemid 34229356)
98. Konduri KS, Nandedkar S, Duzgunes N, et al. Efficacy of liposomal budesonide in experimental asthma. J Allergy Clin Immunol 2003;111:321-7 (Pubitemid 36228553)
99. Huang Y, Wang C. Pulmonary delivery of insulin by liposomal carriers. J Control Release 2006;113:9-14 (Pubitemid 43818162)
100. Bi R, Shao W, Wang Q, et al. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J Drug Target 2008;16:639-48
101. Chimote G, Banerjee R. In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis. J Biomed Mater Res B Appl Biomater 2010;94:1-10
102. Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb) 2005b85:415-20 (Pubitemid 41617396)
103. Liu J, Gong T, Fu H, et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008;356:333-44
104. Hu L, Jia Y, WenDing Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery. Pharmazie 2010;65:585-7
105. Ghaffari S, Varshosaz J, Saadat A, et al. Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles. Int J Nanomedicine 2011;6:35-43